CTCs
Researchers Test Single-Cell Whole-Genome Sequencing to Select Therapy in Relapsed Multiple Myeloma
Premium
At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.
OneCell Diagnostics Raises $16M in Series A Round
The precision oncology company plans to bring its OncoIndx Ikon liquid biopsy circulating tumor cell detection test to the US market.
Angle Acquires Option to License NuProbe Pan-Cancer NGS Panel
Angle said the panel would help advance its efforts to develop a liquid biopsy assay for circulating tumor cells and ctDNA.
Advanced Genomics APAC, CancerFree Biotech Partner to Combine NGS, Drug Response Testing
The firms will bring together Advanced Genomics APAC's genomic profiling workflow and CancerFree Biotech's in vitro drug screening technology.
Angle Raises $630K in Open Offer of Shares
The company said the proceeds will strengthen its balance sheet as it works to advance its circulating tumor cell platform for diagnostics and drug development.
Apr 24, 2024
Angle Inks Assay Development Deal with AstraZeneca
Feb 23, 2023
Oct 31, 2022
Aug 18, 2021
May 27, 2021
Mar 31, 2021